Degarelix

Degarelix is a hormone therapy used to treat prostate cancer. It works by blocking the production of testosterone, which helps stop the growth of prostate cancer cells. Additionally, Degarelix is used to reduce symptoms associated with advanced prostate cancer such as pain, urinary retention and anemia. The drug has been found to be an effective, safe, and well-tolerated treatment for prostate cancer, with minimal side effects. Degarelix's use as an effective treatment for prostate cancer in men offers hope for improved patient outcomes.

← International Journal of Prostate Cancer

Related Articles

1 journal(s) found

International Journal of Prostate Cancer

ISSN: Coming Soon
Type: Open Access Journal
Editor: Sam J. Brancato , Holden Comprehensive Cancer Center.
International Journal of Prostate Cancer is a world -wide, peer-reviewed open access journal. The main aim of this journal is to dedicate basic and clinical studies on prostate cancer and to provide rapid turn-around time possible for reviewing and publishing articles. Authors are encouraged to write - up research articles, review, letters, short-c